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ABSTRACT: We studied the effects of the dihydropyridine derivative BAY K 8644 on the membrane potential of B-cells
in mouse pancreatic islets. BAY K 8644, in a dose-dependent manner, decreased the spike frequency but increased the
duration of the spikes elicited by glucose with or without quinine or tetraethylammonium (TEA). These effects were
antagonized by cobalt and nifedipine but not by tetrodotoxin. The interval between spikes was proportionate to the
duration of the spikes and the ratio of the interval to the spike duration was constant at all concentrations of BAY K
8644 tested. Peak inward current, estimated from the derivative of the action potential recorded in the presence of TEA,
was increased by BAY K 8644 and decreased by nifedipine. BAY K 8644 elicited spike activity when the membrane
was moderately depolarized by either 5.6 mM glucose or 15 mM K+, but did not change the membrane potential of the
resting hyperpolarized B-cell. These results suggest that BAY K 8644 acts on the open Ca2"-channels. The threshold
occurs at a membrane potential of -50 mV. Also, the modifications of the shape of the spikes appear to reflect specific
changes in Ca2" entry. We propose the existence of a Ca2"-induced Ca2"-channel inactivation process in the pancreatic
B-cell.
INTRODUCTION
Calcium entry is known to represent a critical event in the
stimulus-secretion coupling process of a wide variety of
secretory cells (26). In pancreatic B-cells, there is a large
body of evidence emphasizing the role of Ca2, in the
process of glucose-induced insulin release (28). The recog-
nition of glucose by the pancreatic B-cell involves a mem-
brane channel modulation that in turn triggers the charac-
teristic B-cell electrical activity (4, 20). Numerous studies
performed to elucidate the ionic mechanisms underlying
the glucose-induced electrical activity point out the role of
modifications in both the Ca2" and K+ conductances
(3-5, 21, 24, 25).
Different Ca2+-channel blockers, such as divalent
cations (Co2,, Mn2+, Mg2+) dihydropyridines (Nifedipine,
nitrendipine), and phenylalkylamines (Verapamil, D 600)
have been used to study Ca2+ channel properties in many
cell types, including the pancreatic B-cell (2, 11, 12, 14, 21,
25). Recently, it has been shown that structural modifica-
tions of dihydropyridine molecules generate a novel class of
components (BAY K 8644, CGP 28392), which have been
proposed to act as Ca2`-channel agonists instead of antago-
nists. These agonists have already been shown to stimulate
cardiac and vascular smooth muscle (23, 27) and to
enhance stimulated catecholamine (10), aldosterone (1 5),
prolactin (9), and insulin secretion (19).
The aims of the present study were to characterize the
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effects of the new "Ca agonist," BAY K 8644, on
pancreatic B-cells whose electrical activity exhibits a
strong Ca2" dependency in order to gain further insight
into the Ca2"-channel properties of these cells in intact
islets.
MATERIALS AND METHODS
All experiments were performed with islets of Langerhans microdissected
from the tail portion of pancreases removed from 3-mo-old female Swiss
Webster albino mice. A single islet of Langerhans was mounted in a
perifusion chamber (40 ,ul volume) and was continuously perifused with a
modified Krebs' solution (120 mM NaCl, 25 mM NaHCO3, 5 mM KCI,
2.56 mM CaC12, 1.1 mM MgCl2), equilibrated with a mixture of 02
(95%) and CO2 (5%). The flow rate was adjusted to 1.5 ml/min and the
temperature was maintained at 370C. The medium contained, as
required: glucose, quinine hydrochloride, tetraethylammonium chloride
(TEA), and tetrodotoxin (TTX) (Sigma Chemical Co., St. Louis, MO);
cobalt chloride (CoC12) (Fisher Scientific Co. Silver Springs, MD); BAY
K 8644 (Miles Laboratories, New Haven, CT); and Nifedipine (Pfizer,
Inc., Brooklyn, NY). When TEA or high concentrations of KCI were
added to the medium, the concentration of NaCl was lowered accordingly
to keep osmolarity constant.
Both BAY K 8644 and Nifedipine were first dissolved in dimethylsul-
foxide (DMSO) and further diluted in the perifusing medium so that the
final concentration of the organic solvent never exceeded 0.1% (vol/vol).
The control medium contained the same concentration of DMSO as the
experimental medium. DMSO up to 0.1% failed to affect the B-cell
membrane potential or electrical activity. Experiments were conducted
with minimal light to prevent photodegradation of the dihydropyridines.
The electrophysiological methods used in the present study have been
described in detail elsewhere (1). Briefly, the membrane potential was
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measured between two Ag-AgCl electrodes, one in the bathing solution
and the other in the intracellular micro-electrode. The microelectrodes
were prepared with 0.7 mm ID single glass capillary tubing with an inner
fiber (Frederick Haer, Brunswick, MN) and pulled with a Narishige
model PE 2 electrode puller. The glass microelectrodes were filled with
a 1:1 mixture of 3 M KCI and 2 M KCitrate and had tip resistances
of -2 x 108 Q. Membrane potential was recorded using a low noise
differential amplifier. To identify the B-cell, we made impalements in the
presence of 11.1 mM glucose. Experiments were performed on cells that
showed a stable membrane potential and a regular burst pattern of
activity during a 15-min period. Membrane potential was recorded on a
4-channel magnetic tape recorder (Store 4, Racal Thermionic Ltd.,
Sarasota, FL) and reproduced on a dual-channel ink recorder (Brush
recorder, model 220 [Gould, Inc., Oxnard, CA]).
For small cells, the cytosolic potential may be considered to be
equi-potential and the ionic current flowing through the membrane (Ij)
can be taken to be proportional to the rate of depolarization (dV/dt) (7).
Thus, Ii = -Cm d V/dt, where Cm represents the membrane capacity and
d V/dt the time derivative of the membrane potential. Assuming a
pancreatic B-cell surface area of 500 ,um2 and a membrane capacity of 1
AF/cm2, the analysis of the maximum rate of depolarization, d V/
dt(max), of the spike can give a good approximation of the peak inward
current.
The maximum rate of depolarization of the action potential was
measured using a Nicolet 4094 digital oscilloscope (Nicolet Scientific
Corp., Northvale, NJ). The duration of the spikes was calculated as the
time spent between the ascending phase and the descending phase, taking
the foot of the spike as the reference membrane potential. The interval
between spikes was taken as the time between the bottom of the
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descending phase and the foot of the following spike. Each test substance
was added for at least 5 min and the measurements of steady-state spike
frequency, intervals between spikes, and spike duration were made during
the last 3 min of exposure to the drug. During this study, 62 experiments
were performed and the figure are representative of typical experiments.
RESULTS
Effects of BAY K 8644 at Different
Membrane Potentials
In the absence of glucose, the pancreatic B-cell membrane
potential remains at a hyperpolarized level around -70
mV (Fig. 1 A). Under these conditions, the addition of
BAY K 8644 (1 ,uM) did not induce measurable changes in
the resting membrane potential.
Increasing the glucose concentration to 5.6 mM depolar-
ized the membrane, which reached a new stable potential
around -50 mV (Fig. 1 B). In the presence of 5.6 mM
glucose, a 40-mV amplitude spike was recorded 90 s after
the addition of BAY K 8644 (1 ttM). The spike was
followed by a long lasting and slowly reversible hyperpolar-
ization; and when the membrane potential reached its
previous level, a new spike was elicited. The second spike
was recorded after the removal of BAY K 8644. In two
experiments, when the depolarizing effect of 5.6 mM
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FIGURE 1 Effects of BAY K 8644 at different membrane potentials. Effects of 1 ,uM BAY K 8644 on B-cell membrane potential recorded in
the absence of glucose (A), in the presence of 5.6 mM glucose (B), or in the presence of 15 mM K+ (C) in the external medium.
BIOPHYSICAL JOURNAL VOLUME 48 1985920
glucose was <15 mV, the addition of BAY K 8644 (1 ,uM)
failed to induce the appearance of spikes.
In the absence of glucose, a sudden elevation of external
K+ to 15 mM rapidly depolarized the membrane and no
action potentials were elicited. The membrane potential
reached a steady level of -40 mV. Addition of BAY K
8644 (1 ,uM) rapidly elicited several spikes (Fig. 1 C). The
duration of the action potentials increased from 120 ms
to >3 s. The amplitude also increased during exposure to
the drug (from 12 to 26 mV). In the presence of 15 mM
K+, the undershoot following the larger spikes was less
marked than in the presence of 5.6 mM glucose.
To determine the effects of BAY K 8644 at a membrane
potential close to the potential at the peak of the spikes,
which is around -15 mV (8), we increased K+ from 5 to
50 mM (data not shown). Addition of BAY K 8644 (1
AtM) after 5 min in 50 mM K+ did not affect the
membrane potential.
Effects of BAY K 8644 in the Presence of
1 1.1 mM Glucose
BAY K 8644 (1 AM) induced several modifications of the
burst pattern of electrical activity recorded in the presence
of 11.1 mM glucose (Fig. 2). After addition of the Ca2+-
channel agonist, the silent phase of the burst was tran-
siently abolished and the membrane remained depolarized
at the plateau potential. Spike activity was increased (Fig.
2 A). Then, the membrane spontaneously hyperpolarized
and, after 3 min of exposure to BAY K 8644, the silent
phase reached a new potential, -10 mV more negative
than in the absence of the drug. The duration of each burst
was lengthened and the burst frequency was decreased
A
from 4 to 3 bursts/min. Also, the duration of the silent
phase was increased from an average of 4.59 ± 0.14 to
6.75 ± 0.41 s after addition of the drug.
Details of the electrical activity recorded before (Fig. 2
B, a), during (Fig. 2 B, b), and after (Fig. 2 B, c) exposure
to BAY K 8644 (1 ,M) are shown with an expanded time
base in Fig. 2 C. In the presence of the drug, the number of
spikes elicited during the active phase of the burst was
dramatically reduced. However, the duration of the spikes
was increased, lasting on occasion >1 s (compared with
0.08 s in the absence of the drug). Although the potential
at the peak of the spikes was nearly constant (compare
records in Fig. 2 C), the potential at the end of the
repolarization phase of the spikes was 20-25 mV more
negative than in control bursts, reaching a potential value
similar to that of the silent phase of the burst. Also the
shape of the spikes was affected (Fig. 2 C); this was even
more obvious for the larger spikes. The spikes exhibited a
biphasic, sawtooth-like ascending phase and a rapid
descending phase.
After the removal of BAY K 8644, the potential of the
silent phase slowly depolarized and, usually after - 10 min,
reached a value similar to that recorded before the admin-
istration of the drug. A slight increase in the spike
frequency was always recorded, but even 30 min after
removal of BAY K 8644, the burst remained lengthened
and the characteristics of the spikes altered (Fig. 2 C,
compare c to a).
Finally, if the drug was added for a short period of time
to an electrically silent cell, the subsequent addition of 1 1.1
mM glucose induced a bursting activity similar to that
illustrated in Fig. 2.
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FIGURE 2 Effects of BAY K 8644 in the presence of 1 1.1 mM glucose. Effects of 1 gM BAY K 8644 on 1 1.1 mM glucose-induced electrical
activity (A). Details of burst (B) and spikes from the same burst (C) recorded before (a), during (b), and after (c) addition of the drug.
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Effects of Various Concentrations of
BAY K 8644 on the Spike Activity
Induced by High Glucose
At high glucose concentration, the membrane remained
depolarized at the plateau potential and continuous spike
activity was generated (Fig. 3 A), as previously described
(20). The spike frequency, as well as the shape of the spikes
elicited by 22.2 mM glucose, were fairly constant, although
occasionally a spike showing a double peak was recorded
(Fig. 3 B, a). Three concentrations of BAY K 8644 were
tested. After addition of 100 nM BAY K 8644, the
duration of the spikes was increased from 151.7 + 3.3 to
314.5 ± 23.7 ms and the recording of a double or multiple
peaked spike was a common occurrence (Fig. 3 B, b). The
spike amplitude was not significantly affected, but the
spike frequency was reduced from 3.92 to 2.43 spikes/s.
Raising the BAY K 8644 concentration to 500 nM or 1
,uM, induced a further reduction in spike frequency and a
further increase in duration. The ascending phase of the
spike was biphasic (Fig. 3 B, c and d). The slow component
arose from a hyperpolarized membrane potential value
generated by the undershoot of the preceding action poten-
tial. It was generally observed that the larger the under-
shoot of the spike, the slower the initial part of the
ascending phase of the following spike. As soon as this
initial component reached a membrane potential value
roughly equal to the threshold value from which the spike
arose in the absence of the drug, a second steeper compo-
nent appeared that rapidly brought the membrane poten-
tial to the peak value of the spike. The falling phase of the
spikes was steeper. At the peak potential of the spikes, a
succession of rapid fluctuations occurred, as also observed
in the presence of 11.1 mM glucose (Fig. 2 C, b). These
fluctuations were higher in the presence of 500 nM than in
the presence of 1 ,uM BAY K 8644, but their amplitudes
never exceeded 10 mV. The elongated spikes occurred in
doublets, the second spike always lasting two to three times
the duration of the first (Fig. 3 B, c and d). The effects of
BAY K 8644 were irreversible, spike activity remaining
altered 30 min after removal of the drug.
Effects of BAY K 8644 in the
Presence of Quinine
To test the possibility that the effects of BAY K 8644 on
the B-cell action potential could be mediated by modifica-
tions of the Ca?'-activated K+-channel, experiments were
carried out in the presence of quinine, a drug known to
block this channel in various cells, including the pancreatic
B-cell (3). Addition of 100 ,uM quinine in the presence of
11.1 mM glucose abolished the burst pattern, inducing
continuous spike activity (Fig. 4 A, a and b). Quinine also
slightly increased spike duration (Fig. 4 B, a and b).
Addition of BAY K 8644 (1 ,iM) in the presence of both
100 ,uM quinine and 11.1 mM glucose induced similar
modifications as those described in the presence of 22.2
mM glucose. While the potential at the peak of the spikes
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FIGURE 3 Effects of BAY K 8644 in the presence of 22.2 mM glucose. Effects of 100 nM, 500 nM, and 1 IAM BAY K 8644 on 22.2 mM
glucose-induced electrical activity (A). Details of spikes (B) recorded before (a) and during the presence of 100 nM (b), 500 nM (c), or 1 JAM
(d) BAY K 8644, as indicated under the traces in A. All records from the same experiment.
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FIGURE 4 Effects of BAY K 8644 in the presence of glucose and quinine. B-Cell electrical activity recorded in the presence of 1 1.1 mM
glucose (A, a) and after subsequent additions of 100,uM quinine (A, b), 1 MM BAY K 8644 (A, c), and 250M,M CoCl2 (A, d). Details of spikes
(B) recorded in a, b, c, and d. All records from the same experiment.
was unaffected, the spike frequency was reduced from 2.73
to 0.16 spikes/s. The duration of the spikes was 10 times
longer than in the presence of both glucose and quinine and
30 times longer than in the presence of glucose alone (Fig.
4 B, a-c). The spikes were followed by an undershoot -10
mV more negative than the potential at the foot of the
spike.
Addition of Co2, (250 ,uM CoCl2), a Ca2+-channel
blocker, in the presence of BAY K 8644, partially reversed
the modifications induced by the drug (Fig. 4 B, d). The
I GLUCOSE 11.1mM
mv A
-40
-80 L
1 min.
spike duration was reduced from 2.09 ± 0.09 to 1.59 +
0.13 s, while the spike frequency was slightly increased,
from 0.16 to 0.18 spikes/s. Also, the spikes arose from a
less negative membrane potential and their undershoots
were almost completely abolished.
Effects of BAY K 8644 in the
Presence of TEA
To better characterize the effects of BAY K 8644, experi-
ments were carried out in the presence of TEA, a blocker of
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|GLUCOSE 11.1mM l TEA 20mM
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FIGURE 5 Effects of BAY K 8644 in the presence of glucose and TEA. B-cell electrical activity recorded in the presence of I 1.1 mM glucose
(A) and after subsequent additions of 20 mM TEA (B), and 1 MM BAY K 8644 (C). All records from the same experiment.
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the voltage-gated K+-channel (5). Addition of 20 mM
TEA to a medium containing 11.1 mM glucose, changes
the burst pattern to a continuous spike activity (Fig. 5 B).
The spikes occur from a potential slightly more negative
than the silent phase recorded during glucose stimulation
without TEA. The average spike frequency is reduced in
the presence of TEA, but the spike amplitude is increased,
the peak potential usually reaching positive values. Most
importantly, the shape, size and frequency of the spikes are
very regular in the presence of TEA, unlike the irregular
spikes recorded during the burst pattern, making a quanti-
tative analysis of the underlying currents feasible. It can be
seen in Fig. 5 that addition of 1 MuM BAY K 8644
hyperpolarized the membrane and reduced spike frequen-
cy. Details of the modifications induced by BAY K 8644
are illustrated in Figs. 6, 8, and 9 with an expanded time
base.
Dose-dependent Effects ofBAYK 8644 on Spike
Activity. The effects of increasing concentrations of the
mv
L GLUCOSE 11.1mM + TEA 2OmM
a
1s
Ca2"-channel agonist on the spike activity recorded in the
presence of glucose and TEA showed that the modifica-
tions induced by the drug were dose-dependent (Fig. 6).
From 1 nM to 10 ,uM, a progressive increase in the spike
duration was observed (Figs. 6 and 7). The average spike
duration increased from a control value of 322.5 ± 4.6 to
342.9 + 4.0, 386.7 + 4.4, 457.9 ± 5.0, 1,156.8 ± 77.9, and
1,186.7 ± 24.1 ms in the presence of 1 nM, 10 nM, 100
nM, 1 ,uM, and 10 ,uM BAY K 8644, respectively. At 10
,uM, the average spike duration was not significantly
different from that recorded at 1 gM (P > 0.5). At
concentrations exceeding 10 ,M, the average spike dura-
tion decreased from 1,186.7 + 24.1 ms in the presence of
10OgM BAY K 8644 to 908.6 9.4 and 771.7 ± 11.7 ms in
the presence of 50 and 100 AM BAY K 8644, respectively
(Figs. 6 and 7).
The modifications in the spike duration were accompa-
nied by changes in the spike frequency. Fig. 7 shows that as
spike duration increases with the concentration of BAY K
8644 up to 10 uM, spike frequency decreases. Further-
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FIGURE 6 Spike duration at various BAY K 8644 concentrations. Effects of increasing concentrations of BAY K 8644 (as indicated above
each record) on the spikes elicited by 1 1.1 mM glucose and 20 mM TEA. All records from the same experiment.
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FIGURE 7 Dose-response curve for BAY K 8644 and Nifedipine in terms of spike duration and spike frequency. Spike duration (left
ordinate, filled symbols) and spike frequency (right ordinate, open symbols) as a function of the concentration of BAY K 8644 (circles) and
Nifedipine (squares). Glucose, 1 1.1 mM, and TEA, 20 mM, were present in all experiments.
more, the interval between the spikes was proportionate to
the duration of the preceding spike. The ratio of the
interval to the spike duration was constant at spike dura-
tions from 300 to 1,200 ms, at all concentrations ofBAY K
8644 tested, and averaged 6.2 ± 0.4 (n = 364). Similar
observations, but in the opposite direction, were made in
the presence of the Ca-channel antagonist, Nifedipine, and
are included for comparison in Fig. 7 (see Results, below,
remarks on Fig. 10). It should be noted that the membrane
potential recorded at the foot of the spikes was unchanged
by BAY K 8644 concentrations from 1 nM to 100 nM but
was 8-10 mV more negative at BAY K 8644 concentra-
tions exceeding 100 nM. The spike amplitude was fairly
constant at all concentrations tested.
Increasing BAY K 8644 concentrations from 1 nM to 1
,uM induced a progressive increase in peak inward current.
At concentrations exceeding 10 ,uM, the peak inward
current was lower than the control value measured before
the addition if BAY K 8644 Table I, A.
Effects ofBAY K 8644 in the Presence of TTX
and CoC12. To assess the specificity of BAY K 8644 in
B-cells, we performed experiments in the presence of the
Na+-channel blocker, TTX, or the Ca2"-channel blocker,
Co2". The addition of TTX (1 ,uM) had no effect on the
action potentials evoked by glucose and TEA (Fig. 8, a and
b). Peak inward current averaged - 17.42 ± 0.39
and - 17.37 ± 0.55 pA before and after addition of TTX,
respectively. In the presence ofTTX, BAY K 8644 (1 uM)
induced the same modifications of the action potential as in
the absence of the Na+-channel blocker; peak inward
current (Table I, B), spike duration and membrane poten-
tial recorded at the foot of the spikes were increased (Fig.
8). Addition ofTTX (1 uM) 5 min after the application of
BAY K 8644 (1 ,M) did not change the effects of the
Ca2+-agonist (data not shown).
On the other hand, the effects of BAY K 8644 were
counteracted, in a dose-dependent manner, by the addition
of Co2+, a Ca2+-channel blocker. Increasing the Co2,
concentration decreased the spike duration from 1,195.8 +
51.5 ms (measured in the presence of 1 ,uM BAY K 8644
alone) to 773.3 ± 48.0, 429.1 ± 8.4, and 265.5 ± 6.6 ms in
the presence of 100, 250, and 500 ,M Co2+, respectively.
The increase in peak inward current elicited by BAY K
8644 was also antagonized by addition of Co2, (Table I, B)
In the presence of 1 mM Co2+ the spike activity was
blocked and the membrane was depolarized by 11 mV
(Fig. 8 g).
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TABLE I
PEAK INWARD CURRENT (IN PICOAMPS)
A TEA TEA TEA TEA TEA TEA TEA TEA
BAY 1 nM BAY1OnM BAY 100 nM BAY 1,uM BAY10,M BAY 50uM BAY 100AM
12.10 ± 0.26 12.62 ± 0.33 12.94 ± 0.32 12.98 ± 0.31 14.23 ± 0.53 13.11 ± 0.21 11.23 + 0.24 9.84 ± 0.09
n=22 n=23 n=21 n=22 n= 14 n= 18 n= 18 n= 14
B TEA TEA TEA TEA TEA TEA
TTX 1,uM TTX 1,uM TTX 1,M TTX 1,uM TTX 1I M
BAY1uM BAY 1AM BAY 1,uM BAY1uM
Co2+ 100 AM Co2+ 250gM Co2+ 500,uM
17.42 ± 0.39 17.37 + 0.55 18.57 ± 0.11 18.05 ± 0.07 16.08 ± 0.59 14.00 ± 0.31
n= 13 n =9 n= 15 n= 15 n=7 n=7
C TEA TEA TEA
BAY 1AM BAY 1gM
NIF 10AM
15.78 ± 0.08 16.89 ± 0.09 8.77 ± 0.14
n= 17 n= 15 n = 9
D TEA TEA TEA TEA
NIF 100 nM NIF 1gM NIF 10uM
12.75 ± 0.10 11.21 ± 0.23 10.05 + 0.11 5.94 ± 0.07
n= 13 n= 10 n= 11 n= 15
To calculate the peak inward current, the B-cell membrane capacity was taken as 5 pF. Concentration of TEA was 20 mM throughout. Results are
expressed as the mean (± SEM) with the number of individual spikes analyzed (n). BAY, BAY K 8644; NIF, Nifedipine.
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FIGURE 8 Antagonistic action of CoC12. Action potentials recorded in the presence of 11.1 mM glucose and 20 mM TEA (a) and after
subsequent additions of TTX (b), BAY K 8644 (c), and CoCl2 (d, e,f, and g) at the concentrations indicated above each record. All records
from the same experiment.
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Reversal of BAY K 8644 effects by Nifedi-
pine. Nifedipine, an organic Ca2"-channel antagonist
(11, 12, 14), was tested in the presence of BAY K 8644 (1
,uM). Addition of 10 ,M Nifedipine rapidly suppressed the
spike activity and progressively depolarized the B-cell
membrane (Fig. 9 A). As the membrane depolarized (- 15
mV), the spikes reappeared and the spike frequency
increased progressively. The analysis of the spikes showed
that the Ca2"-antagonist reversed the modifications
induced by BAY K 8644 (Fig. 9 b). In the presence of
BAY K 8644, addition of Nifedipine reduced spike dura-
tion by 55%, spike amplitude by 38%, and peak inward
current by 48% (Table I, C). Similar effects were recorded
with 1 MM Nifedipine, except that the depolarization was
only -4 mV (data not shown).
After removal of Nifedipine, both the membrane poten-
tial at the foot of the spikes and the spike amplitude were
increased, while the spike duration was lengthened. How-
ever, the effects of Nifedipine were never completely
reversible (Fig. 9 B, d).
Dose-dependent Effects of Nifedipine on
Spike Activity
For the purpose of comparison, Nifedipine was tested on
the spike activity induced by glucose and TEA. Addition of
Nifedipine (0.1-1 MM) did not affect the membrane
potential at the foot and at the peak of the spike. However,
addition of 10 MM Nifedipine transiently reduced spike
frequency and the membrane potential at the foot of the
spikes slowly decreased (Fig. 10 A, d). After the mem-
brane depolarized - 16 mV, spike frequency again
increased, but spike amplitude decreased. The duration of
the spikes was decreased, from 274.5 ± 3.5 ms before
addition of Nifedipine, to 260.4 ± 3.3, 214.0 ± 2.0, and
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143.0 ± 1.8 ms in the presence of 100 nM, 1 ,tM, and 10
,uM Nifedipine, respectively (see Figs. 7 and 10 B); peak
inward current was reduced by 12%, 21%, and 53%,
respectively (Table I, D). Spike frequency was not altered
by 100 nM Nifedipine, but was increased, from 0.43
spikes/s before addition of Nifedipine, to 0.52 and 0.73
spikes/s, in the presence of 1 and 10 ,M Nifedipine,
respectively (Fig. 7). The interval between the spikes was
proportionate to the duration of the spikes. The ratio of the
interval to the spike duration was constant at spike dura-
tions from 140 to 275 ms, at all concentrations of Nifedi-
pine tested, and averaged 8.1 ± 0.2 (n = 328).
The effects of Nifedipine were not reversed even 20 min
after the removal of the Ca2+-channel antagonist (Fig.
10 A and B, e).
DISCUSSION
BAY K 8644, a lipophylic dihydropyridine derivative, has
been proposed to stimulate Ca2, influx in different cell
types (9, 10, 15, 19, 23, 27). Analysis of the drug effects at
the level of single Ca2"-channels revealed that the ampli-
tude of the Ca2"-channel unitary current was unaffected,
but both mean open time and opening probability were
increased (13, 16).
BAY K 8644 Is a B-Cell Ca2"-Channel Ago-
nist. In excitable membranes, the shape of the action
potential is known to be determined primarily by the
characteristics of the inward depolarizing and the outward
repolarizing currents (14). Modifications of either of these
two components will affect action potential shape.
In the present study we have shown that BAY K 8644
increased the maximum rate of depolarization and pro-
longed the spike duration, both parameters previously
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FIGURE 9 Antagonistic action of Nifedipine. Effects of addition of 1 ,uM BAY K 8644 and 10 ,uM Nifedipine on the electrical activity
induced by 11.1 mM glucose and 20 mM TEA (A). Details of spikes (B) recorded in the presence of glucose and TEA (a), after addition of
BAY K 8644 (b) or Nifedipine (c), and 10 min after removal of Nifedipine (d). All records from the same experiment.
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FIGURE 10 Effects of Nifedipine in the presence of glucose and TEA. Effects of increasing concentrations of Nifedipine (as indicated above
the records) on the electrical activity induced by 1 1.1 mM glucose and 20 mM TEA (A). Details of spikes (B) recorded in the presence of
glucose and TEA (a) or after the addition of Nifedipine (b, c, and d) and 5 min after removal of Nifedipine (e). All records from the same
experiment.
shown to be Ca2"-dependent (4, 24). Furthermore, cobalt,
an inorganic Ca2+-channel antagonist, and Nifedipine, an
organic Ca2+-channel antagonist, reversed the modifica-
tions of the B-cell action potential evoked by BAY K 8644,
suggesting that the effects ofBAY K 8644 are mediated by
direct actions on B-cell Ca2+-channels (17). Facilitation of
Ca2" influx by BAY K 8644 in pancreatic B-cells is further
supported by recent observations showing that the drug
enhanced the glucose-stimulated net uptake of 45Ca; in the
presence, but not in the absence, of extracellular calcium,
BAY K 8644 stimulated 45Ca outflow from rat pancreatic
islets preloaded with 45Ca (19).
The prolongation of the B-cell action potential and the
increase in peak inward current induced by BAY K 8644
were not antagonized by TTX, a specific Na+-channel
blocker. Furthermore, the increase in spike duration was
larger than that induced by quinine, a blocker of the
Ca2+-activated K+-channel (3), or TEA, a blocker of the
voltage-gated K+-channel (5). Indeed, addition of BAY K
8644 in the presence of quinine or TEA further increased
the spike duration about fourfold. Thus, these results
support the view that BAY K 8644 specifically enhances
Ca2' entry during the action potential.
The progressive reduction of spike duration recorded at
the higher concentrations of BAY K 8644 (50-100 ,uM)
are probably due to a decrease in Ca2' entry because the
drug also inhibited the peak inward current over the same
concentration range. Furthermore, it was previously shown
that 87 ,uM BAY K 8644 decreased glucose-induced
insulin release (19). Thus, at high concentrations, the drug
may lose some specificity as a Ca2+-channel agonist and
could act as a dihydropyridine Ca2+-channel antagonist
(10).
Finally, the finding that in the presence of glucose and
TEA the shape of the action potential and the derived
inward current are not affected by TTX reinforces the view
that Na+-channel activation is not involved in the genera-
tion of action potentials in the normal B-cell.
BAY K 8644 Acts on the Open Ca2+-channel in
B-Cells. BAY K 8644 induced spike activity in the
presence of either 5.6 mM glucose or 15 mM K+, when the
membrane potential was near -50 mV, but failed to
induce electrical activity when the membrane potential of
the cell was near -70 mV. These findings suggest that
there is a threshold membrane potential for BAY K 8644
action in the B-cell. This is in good agreement with
previous observations showing that, at the single Ca2+-
channel level, the drug did not induce spontaneous open-
ings when the membrane was held at a very negative
potential (16). It has also been observed that a moderate
depolarization is required for the drug to manifest its
potentiating effect on secretion (10, 15, 19). Recently, the
voltage-dependency of Ca2`-channel activation in the B-
cell has been derived from the dependency of the recovery
time after brief exposures to elevated K+ concentrations. It
was found that there is a sigmoidal relationship between
the fraction of Ca2+-conductance activation and mem-
brane potential, with 50% channel activation occurring
at -27 mV (8). The results presented here, showing that
BAY K 8644 was ineffective at potentials more negative
than about -50 mV, suggest that at least 10% of the B-cell
Ca2+-channels must be activated for the drug to induce an
action potential.
Action Potential Duration Reflects Ca2+ In-
flux. BAY K 8644 has been reported to evoke a dose-
dependent increase in the duration of the action potential
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in new born rat heart cells that was paralleled by an
increased rate of 45Ca uptake and an increased contractil-
ity (23). Also, in adult guinea pig ventricular cells, the
prolongation of the action potential evoked by various
concentrations of BAY K 8644 was accompanied by a
concomitant increase in maximum Ca current (6). The
results presented here with BAY K 8644, Nifedipine, and
cobalt also show a positive correlation between the spike
duration and the peak inward current. Nifedipine, a selec-
tive Ca2"-channel blocker, induced a dose-dependent
decrease in peak inward current, which was accompanied
by a concomitant shortening of the spikes. On the other
hand, low concentrations of BAY K 8644 increased both
peak inward current and spike duration.
In the presence of 11.1 or 22.2 mM of glucose, the
elongated spikes elicited by BAY K 8644 were followed by
an undershoot. This negative after-potential was reduced
by quinine and, thus, appears to be due to stimulation of
Ca?'-activated K+-channel. Furthermore, since the ampli-
tude of the undershoot was also reduced by Co2", it can be
considered as an indirect reflection of the entry of Ca2"
during the spikes. In all the experiments performed, the
amplitude of the undershoot paralleled the spike duration:
the longer the spike, the larger the undershoot. In the
presence of TEA, the membrane potential recorded
between the spikes also depends on the Ca2"-activated
K+-channel. This potential was increased when the effects
of BAY K 8644 on the spike duration were maximal and
was decreased when the effects of Nifedipine on spike
duration were maximal.
Thus, the present data suggest that under the present
experimental conditions the modifications in spike dura-
tion parallel changes in Ca2" influx. This is in agreement
with previous work showing that BAY K 8644 stimulated
the Nifedipine inhibited, both in a dose-dependent way, the
glucose-stimulated insulin release (18, 19).
Intracellular Ca2" May Inactivate Ca2`-Chan-
nels in Pancreatic B-Cells. Among its numerous proper-
ties, the Ca2"-channel has been proposed to exhibit some
form of inactivation that is time- and, to some extent,
voltage-dependent, but especially Ca?'-dependent
(12, 14, 22). According to this hypothesis, as Ca2" ions
flow during action potential, there is a local rise of intracel-
lular free-calcium, which in turn causes inactivation of the
Ca2"-channel. The channel remains refractory until the
internal free-calcium concentration is reduced.
The results reported here with either BAY K 8644 or
Nifedipine could be explained by assuming the existence of
such an inactivation process in the pancreatic B-cell. As
discussed above, if the increase in spike duration reflects an
increase in Ca2" entry, then the increase in Ca?' should
inactivate the Ca2"-channel and increase the refractory
period. This should lengthen the interval between spikes
and decrease spike frequency. Conversely, a decrease in
Ca2+ entry during the spikes should shorten the duration of
intervals between the spikes and, therefore, increase spike
frequency. The present data confirm these expectations,
namely, the dose-dependent changes in spike duration
evoked by BAY K 8644 or Nifedipine were accompanied
by parallel changes in the intervals between spikes (the
ratio of the interspike interval to spike duration was
constant) and by opposite modifications in the spike fre-
quency (see Fig. 7). Since these modifications in spike
duration and frequency were independent of changes in the
membrane potential, they probably indicate the existence
of a Ca?'-dependent Ca2"-channel inactivation process in
the pancreatic B-cell.
Effects ofBAYK 8644 on Glucose-induced Elec-
trical Activity. Ca?+-Activated K+-channels have been
proposed to be involved in the control of the pancreatic
B-cell burst pattern of electrical activity. For example,
increasing extracellular Ca2" concentration increased the
duration of the silent phase and decreased the frequency of
the bursts; decreasing Ca2` was shown to decrease both the
maximum repolarization potential between the bursts and
the duration of the intervals between them (4, 21, 25).
Thus, the progressive hyperpolarization of the membrane
potential at the silent phase of the burst as well as the
increase in the relative duration of the silent phase and the
decrease in burst periodicity induced by BAY K 8644 are
consistent with the hypothesis that the burst activity is
mainly governed by Ca?+-activated K+-channels.
Some details of the shape of the action potentials in the
presence of BAY K 8644 deserve comment. The spikes
exhibit a biphasic rising phase (see Fig. 2 C, b and Fig. 3 B,
c and d). The initial slow component of the rising phase of
the spike is probably caused by the Ca2+ load from the
preceding spike. As Ca?+ is lowered, the membrane is
depolarized and the threshold potential for the activation
of Ca2+-channels is reached, initiating the fast component
of the rising phase. The membrane potential at which the
fast component was initiated was not changed by BAY K
8644.
Another interesting feature of the spikes recorded in the
presence of BAY K 8644 is the presence of small potential
fluctuations (5-10 mV) along the plateau of the action
potential. These potential fluctuations disappeared in the
presence of quinine or TEA, when the potential at the
plateau was more depolarized, and could reflect Ca 2+-
channel bursting to open state. Ignoring changes in mem-
brane resistance accompanying the recruitment of open
Ca2+-channels and taking the size of the elementary
Ca2+-channel voltage event in pancreatic B-cells as -53
,uV (2), these small potential fluctuations could be viewed
as the synchronized opening of a few hundred Ca2-
channels.
BAY K 8644 Affinity for the B-Cell Ca2+-
Channel. The existence of a dihydropyridine binding site
or receptor closely associated with the calcium channel has
LEBRUN AND ATWATER Effects ofElectrical Activity in Pancreatic B-Cells 929
been reported in many tissues and its properties are
consistent with its being a glycoprotein macromolecule
(1 1). In our hands, the effects of BAY K 8644 were rapid
in onset, but slowly reversible. This feature, and the finding
that the drug exhibited an effect at very low concentra-
tions, are in support of the existence of high affinity sites in
the pancreatic B-cell.
On the other hand, although the onset of the effects of
BAY K 8644 were voltage-dependent, its binding proper-
ties appeared to be voltage-independent. Indeed, the
effects of BAY K 8644 could be evoked by depolarization
after previous exposure of the hyperpolarized cells to the
drug. This finding is consistent with the idea that the
dihydropyridines, including BAY K 8644, which are
highly lypophylic agents, may have access to their targets
through the lipid phase of the membrane (6, 16).
In summary, electrophysiological evidence is provided
for the first time in pancreatic B-cells that BAY K 8644, a
new dihydropyridine drug shown to act as a Ca2"-channel
agonist in other systems, increases Ca2" entry in response
to depolarization of the B-cells. The data also provide the
first indication for the existence of Ca?'-induced Ca2`-
channel inactivation in the B-cell. The drug proves a useful
tool in investigating the various repercussions on mem-
brane potential that an increase of Ca2" influx could have
in B-cells within the intact islet.
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